A brief review of this GWAS for Bipolar Disorder:
Genome-wide association study of over 40,000 bipolar disorder cases provides novel biological insights (Mullins et al. )
Like almost all the behavioral genetic GWAS studies, this one uses a meta-analysis, despite having new data added to previous data and the new data was never assessed (at least in print) independently. Thus, it is difficult to assess statistically what is success and what is failure, although it is filled with the usual accolades:
This GWAS provides the best-powered BD polygenic scores to date, when applied in both European and diverse ancestry samples. Together, these results advance our understanding of the biological etiology of BD, identify novel therapeutic leads and prioritize genes for functional follow-up studies.
Well, the best and the only, really. But, of course, I have a lot of questions. The first is related to their significant loci count, and for which I needed partial clarification from one of the authors, as I will discuss after the fold (click "read more" to continue).